Table 2.
Laboratory values by DOPPS country (2012–2015)
| Laboratory value | Europe | Rus | Asia and Middle East | North America | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bel | Fra | Ger | Ita | Spa | Swe | UK | Chi | Jpn | KSA | Can | USA | ||
| Mean (SD) total calcium, mg/dL | 9.0 (1.1) | 8.8 (1.3) | 8.8 (1.4) | 8.9 (1.3) | 8.9 (1.2) | 9.1 (1.1) | 9.2 (1.4) | 8.8 (1.7) | 9.0 (2.1) | 8.8 (1.3) | 8.7 (1.8) | 8.8 (1.7) | 9.0 (0.8) |
| Mean (SD) phosphorus, mg/dL | 4.6 (2.4) | 4.4 (2.7) | 5.4 (2.8) | 4.8 (2.3) | 4.6 (2.3) | 5.2 (2.2) | 4.8 (2.6) | 5.3 (3.0) | 6.0 (4.3) | 5.4 (2.4) | 5.2 (4.5) | 5.0 (3.3) | 5.1 (1.7) |
| Mean (SD) iPTH, pg/mL | 346 (561) | 399 (661) | 262 (429) | 313 (506) | 336 (512) | 379 (497) | 392 (741) | 571 (1182) | 439 (1050) | 150 (233) | 540 (1221) | 431 (812) | 408 (424) |
| Median [IQR] iPTH, pg/mL | 240 [121, 450] | 298 [179, 540] | 192 [92, 357] | 209 [113, 400] | 247 [145, 417] | 287 [161, 468] | 286 [142, 485] | 395 [162, 728] | 284 [138, 518] | 118 [64, 193] | 357 [165, 641] | 332 [190, 532] | 303 [184, 495] |
Bel Belgium, Can Canada, Chi China, DOPPS Dialysis Outcomes and Practice Patterns Study, Fra France, Ger Germany, IQR interquartile range, Ita Italy, Jpn Japan, KSA Kingdom of Saudi Arabia, iPTH intact parathyroid hormone, Rus Russia, Spa Spain, Swe Sweden
Patient data are weighted for the facility sampling fraction